OA pain shows anti-persistent time series  by Schnitzer, T.J. et al.
Table 1
Glutamate levels in diseased PTT and healthy FDL tendons
Group (n[21 each) Glutamate Concentration
(nM/g)
95% Conﬁdence
Interval
Diseased PTT 12.3 +/- 14.3 5.8-18.9
Healthy FDL Tendon 4.9 +/- 3.7 3.19-6.5
Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S261suffering from increased disability and lower physical and mental
health status.
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CHANGES IN KNEE PAIN, PERCEIVED NEED FOR SURGERY, PHYSICAL
FUNCTION AND QUALITY OF LIFE AFTER DIETARY WEIGHT LOSS IN
OBESE WOMEN DIAGNOSED WITH KNEE OSTEOARTHRITIS
K. Coriolano, A. Aiken, M. Harrison, C. Pukall, B. Brouwer, D.
Groll. Queen's Univ., Kingston, ON, Canada
Purpose: The objective of this study was two-fold: 1) to investigate
whether weight loss is associatedwith a reduction in perceived need for
Total Knee Replacement (TKR) surgery due to decrease in knee pain and
improvement in function, 2) to identify what percentage of weight loss
is associated with reduction in knee pain to a point where the need for
surgery could be prolonged or alleviated. 34 subjects were recruited
into the study.
Methods: Women between 40 and 65 years old with morbid obesity
(BMI  35 kg/m2) and osteoarthritis of the knee were pre-selected.
Participants completed the Western Ontario and McMasters (WOMAC)
Universities index, The Short Form Health Survey (SF-36); 6-Minute
Walk Test and Timed Up and Go at baseline and participants were
enrolled into a weight loss program, for a 6 month period.
Results: Repeatedmeasures ANOVA revealed that at 6 weeks of diet the
mean body weight reduction of 9.5%, was followed by a signiﬁcant
reduction (p¼.015) in WOMAC scores and (p¼.038) SF-36 sub score of
physical function. At 3 months of diet a signiﬁcant reduction of 16.5% in
body weight corresponded to a signiﬁcant decrease of 37% in knee pain
and 56% in perceived need for surgery.
Conclusion: These results suggest that an initial loss of 16.5% of body
weight for obese individuals was signiﬁcant enough to reduce pain and
postpone patient's intent to have surgery in 56%. Even though a weight
loss of 16.5% might inﬂuence a patient's choice to undergo TKR surgery,
these ﬁndings might not be extended to the general morbidly obese
population. However, based on our results we expect that a weight loss
of 16.5% might provide a major decrease in knee pain and increase in
function.503
GLUTAMATE IS ELEVATED IN PATHOLOGIC POSTERIOR TIBIAL
TENDONS OF PATIENTS WITH POSTERIOR TIBIAL TENDON
DYSFUNCTION
D. Tainter, R. Bell, D.L. Nettles, L.A. Setton, S.G. Parekh, S.B. Adams,
Jr. Duke Univ. Med. Ctr., Durham, NC, USA
Purpose: Pain is the predominant symptom for many patients with
degenerative orthopedic diseases. Oftentimes the pathophysiology of
pain in orthopedic disease is not well understood, such as in tendons,
which are relatively avascular and aneural. The posterior tibial tendon
(PTT) is critical for inversion of the foot and arch stability. When the PTT
elongates, through repetitive microtears, it results in a syndrome of
signiﬁcant pain and disability called posterior tibial tendon dysfunction
(PTTD). Glutamate is a well-known and potent pain generating excit-
atory neurotransmitter shown to play a role in Achilles and patellar
tendinopathyand as suchweexpect it to playa role in PTTD. The purpose
of this study was to quantify the concentration of glutamate in cultured
media from PTT tendon explants of PTTD patients and healthy controls.
Methods: Samples of PTT and ﬂexor digitorum longus (FDL) were
collected from twenty-one patients undergoing FDL tendon transfer
surgery for stage II PTTD that failed conservative management. The
excised portion of the PTT was dissected from the area of maximum
disease as determined by gross morphology. Healthy FDL tendon was
obtained from trimmings that otherwise would have been discarded.
Diseased and healthy tendon samples were trimmed to make them
approximately the same size per patient. The samples were washed
three times in Dulbecco's modiﬁed essential media (DMEM) and then
weighed. Samples were then incubated in 3 mL of DMEM with 5 mg
penicillin and streptomycin and 12.5 mg HEPES at 37C with 5% CO2 for
48 hours to allow for substance diffusion. After 48 hours, the spent
media was frozen at -80C until use. Sample media was spun down
through a 10 kDa spin ﬁlter (Pall, OD010C34) and glutamate was
detected using a colorimetric assay kit (Sigma Aldrich, MAK004). All
measurements were normalized by mass and analyzed using
a matched-pair t-test.Results: The samples were obtained from 15 females and 6 males with
amean age of 64 years (range, 53 to 76 years). Glutamate levels from the
diseased PTT tendons were signiﬁcantly elevated compared to the
healthy FDL tendons (p ¼ 0.03, Table 1).
Conclusions: The etiology of debilitating pain in PTTD is not well
understood.We found that glutamate levels are signiﬁcantly elevated in
the diseased portion of the PTT in PTTD when compared to healthy FDL
tendon from the same individual. This marked increase in glutamate
concentration may contribute to pain through binding with its iono-
tropic ligand, NMDA, within the tendon or the surrounding tissues.
Characterizing the local production of pain generating excitatory
neurotransmitters potentially improves our understanding of the
pathophysiology of pain and may yield better non-surgical treatment
options.504
CHANGES IN ADL AND LOWER LIMB FUNCTION AFTER TOTAL KNEE
ARTHROPLASTY
Y. Sugawara y, H. Kurosawa y, Y. Shimura y, T. Kawasaki z,
M. Tsuchiya y, M. Sawa y, Y. Iwase y, K. Kaneko z. y Juntendo Tokyo Koto
Geriatric Med. Ctr., Tokyo, Japan; z Juntendo Univ., Tokyo, Japan
Purpose: Total knee arthroplasty (TKA) has been established as an
effective treatment method that decreases knee pain in osteoarthritis
(knee OA). However, it has not been studied sufﬁciently how much
lower limb function and ADL are improved by TKA. The aim of the
present study is to establish whether the disorders in ADL are improved
similarly to pain by using self-administered rating scale and pain VAS.
Lower limb function was assessed by using timed Up & Go test(TUG)
and timed open-eyes one-foot standing (TOFS).
Methods: We examined 56 knees-OA patients (men5 women51)(the
mean age 74.6 years), 71 knees in which we had performed TKA
between July 2011 and September 2012 in our hospital. Patient were
assessed preoperatively and postoperatively at 6M using Japanese Knee
Osteoarthritis (JKOM), a disease-speciﬁc instrument for measuring
clinical outcome in patients treated for knee OA. The lower limb func-
tionwas evaluated using TUG and TOFS. Painwas evaluated using JKOM
subscale ;II Pain and stiffness in Knees, score(0-32) and Visual Analog
Scale (VAS)(0-100mm). Disorders in ADL was assessed by using JKOM
subscale ; III Disorders in usual life, score(0-40).
Results: Regarding pain, VAS and JKOMII were signiﬁcantly improved
by TKA from 70.9(20.0)(SD) to 10.7(13.9),and 18.8(6.4) to 5.4(3.8).
Concerning disorders in ADL, JKOMIII was also signiﬁcantly improved
from 19.8(8.1)to9.0(5.6). As to lower limb function, TUG and TOFS were
also signiﬁcantly improved from 17.4(5.7) to 15.0(5.1) and 13.6(16.6) to
21.4(18.9) sec. Postoperative TUG was signiﬁcantly correlated with
postoperative ADL(JKOMIII) in multiple regression analysis(linear type)
(b¼0.574 95%CI:0.255-0.866 p¼0.01).
Conclusions: Disorders in ADL were improved as well as pain by TKA.
TUG is thought to be useful tools which evaluate lower limb function in
TKA.
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OA PAIN SHOWS ANTI-PERSISTENT TIME SERIES
T.J. Schnitzer, R. Yeasted, L. Huang, M. Baliki, A. Apkarian. Northwestern
Univ. Feinberg Sch. of Med., Chicago, IL, USA
Purpose: The pain associated with osteoarthritis (OA) is the most
common symptom for OA patients, serving as a predictor of reduced
levels of everyday physical activity. Characterizing the pain of OA is
critical to understand mechanisms underlying the disease and to
develop approaches to intervene. However, the research on the
temporal dynamics of OA pain intensity, especially over longer periods
of time, is still rare. In this study, we collected pain ratings from indi-
viduals with knee OA 3 times per day over 3 months to explore the
temporal properties of the pain.
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participants had to be 40 yr of age and meet the ACR deﬁnition for
knee OA. There was no requirement for minimum pain intensity and
management was to be continued as required. All participants were
asked to response to pings prompted from their smart phones and
subsequently rate their knee pain (0: no pain, 10: worst possible) three
times per day over 3months. Each of three daily pings was programmed
to occur at random in each of three 4-hour blocks (8am-noon, noon-
4pm, and 4pm-8pm). To characterize the statistical properties of the
time series of pain ratings, the means of the pain ratings in three blocks
were calculated and compared by one way analysis of covariance. As
well, fractal dimension, D, was calculated using rescaled range analysis
to characterize the OA participants’ pain ﬂuctuations.
Results: Thirty-two individuals participated in the study (18 females,
age (mean, standard deviation) 59.7 6.5 yr; 10 males, 55.36.7 yr). As
shown in Figure A, there is no signiﬁcant difference among the three
blocks of time for the mean rating of pain. Figure B displays the
distribution of fractal dimension, D. calculated for each individual's
mean daily pain intensity. The mean fractal dimension, D, for the
population is 1.650.04, which signiﬁes an anti- persistent pain time
series.
Conclusions: This is the ﬁrst analysis to characterize the fractal
dimension of OA pain. The ﬁnding of anti-persistent time series means
that on average more intense pain is followed by lesser pain, a ﬁnding
very similar to that reported for chronic low back pain and in contrast to
both purely neuropathic pain and acute pain. Whereas these previous
studies were over short time periods, this study suggests that power
law scaling can be preserved for much longer periods of time (weeks or
months), which is signiﬁcant for clinical application. The anti-persistent
pattern of pain is consistent with the concept of central pain processes
activated to modulate peripheral pain input in OA.
Ă
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THE SOURCES OF PAIN IN KNEE OSTEOARTHRITIS ARE CHANGING
DEPENDENT UPON THE PROGRESSION OF THE DISEASE
Y. Shimura y, H. Kurosawa y, M. Ishijima z,x, L. Liu z,x, H. Kaneko z, I.
Futami z, R. Sadatsuki z, A. Yusup z, S. Hada z, M. Tsuchiya y, Y.
Sugawara y, M. Sawa y, Y. Iwase y, K. Kaneko z,x. yDept. of Orthopaedics,
Juntendo Tokyo Koto Geriatric Med. Ctr., Tokyo, Japan; zDept. of Med. for
Orhtopaedics and Motor Organ, Juntendo Univ. Graduate Sch. of Med.,
Tokyo, Japan; x Sportology Ctr., Juntendo Univ. Graduate Sch. of Med.,
Tokyo, Japan
Purpose: Pain is the most prominent and disabling symptom of oste-
oarthritis (OA). Thus, it is important to understand the cause of pain to
optimally treat this common disease. Pain in knee OA is involved in
a nociceptive pain, of which inﬂammation and the detrimental
mechanical stress to the joint are main cause. Recent studies have
shown that OA is associated with the signs and symptoms of inﬂam-
mation, and synovitis is common in OA. Serum levels of interleukin-6
(IL-6) and C-reactive protein (CRP) are reported to be associated with
synovitis and pain severity in knee OA. Walking analysis showed that
pain induced by detrimental mechanical stress due to the knee defor-
mity was positively correlated with pain severity only in advanced stage
of knee OA. However, it's still remained unclear which of these two
factors dominantly contribute to knee OA pain, or do their contributions
to knee OA pain may change according to the OA severity? This studywas conducted to answer these questions by obtaining data from knee
OA patients.
Methods: In this prospective cohort study, one-hundred sixty post-
menopausal women with knee OA, who had complained of knee pain
and provided written informed consent, were enrolled between Oct.
2009 and Dec. 2011. The severity of knee OA was classiﬁed by Kellgren-
Lawrence (K/L) grading scale based on standing extended-knee X-ray
images. Pain was evaluated by a visual analogue scale (VAS, 0-100) and
pain and stiffness sub-category of Japanese Knee Osteoarthritis
Measure (JKOM-pain), which is a patient-oriented outcomemeasure for
knee OA with sufﬁcient reliability and validity, similar to WOMAC and
SF-36. Serum levels of IL-6 and CRP were measured to monitor the
inﬂammation of knee OA. Anatomical axis angle (AAA) on standing
radiograph was measured as the objective indicator for mechanical
stress for lower limb. Univariate and multivariate analyses were con-
ducted to examine the relationships between the pain severities and
several clinical manifestations of knee OA patients.
Results:When a univariate analysis was conducted in all patients, there
was no signiﬁcant correlation between pain scores (pain VAS and
JKOM-pain) and the baseline characteristics, serum levels of IL-6 and
CRP, and radiographic OA severity, including in AAA. When the patients
were divided into two groups according to the radiographic severity of
knee OA, the early- (K/L2;67) and advanced-stage (K/L3 and 4; 93),
there was signiﬁcant positive correlation between serum IL-6 level and
both pain VAS score (r¼0.411, p¼0.001) and JKOM-pain score (r¼0.526,
p<0.001) in the early stage, while in advanced stage no signiﬁcant
correlations were found between these parameters. On the other hand,
there was signiﬁcant positive correlation between AAA and both pain
VAS score (r¼0.224, p¼0.033) and JKOM-pain score (r¼0.298, p¼0.004)
in the advanced stage, while in early stage no signiﬁcant correlations
were found between these parameters. Next, a multivariate analysis
was conducted to ﬁnd out the factors those can explain the pain severity
by loading of age, BMI, serum IL-6 level, serum hs-CRP level and AAA.
No factors were found to explain the pain severity when all patients
were included in the analysis. However, when the analysis was con-
ducted to the patients in early stage, only serum IL-6 level was signif-
icantly correlated with both the JKOM-pain score (b¼0.566,p<0.001)
and pain VAS score (b¼0.411,p¼0.002). When the analysis was con-
ducted to the patients in advanced stage, only AAA was signiﬁcantly
correlated with both the JKOM-pain score (b¼0.330, p¼0.004) and pain
VAS score (b¼0.240, p¼0.037).
Conclusions: The present study suggests that the components of knee
OA pain are changing dependent upon the progression of the disease;
the pain severity in knee OA patients is mainly affected by inﬂamma-
tion, probably synovitis, in early stage, while that of those by detri-
mental mechanical stress in advanced stage.
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EXPLORATORY EVALUATION OF A TREADMILL WALKING MODEL TO
ASSESS TREATMENT-RELATED ANALGESIA IN SUBJECTS WITH
OSTEOARTHRITIS KNEE PAIN
T.A. McNearney y, A. Kivitz z, Y. Jin y, S.L. Myers y, T. Smart x. y Eli Lilly and
Company, Indianapolis, IN, USA; zAltoona Ctr. for Clinical Res.,
Duncansville, PA, USA; x Eli Lilly and Company, Erl Wood ELCL, United
Kingdom
Purpose: Sensitive, relevant and reliable measurements of pain levels
and their relationship to physical function are important for the
development of novel therapeutics for knee osteoarthritis (KOA). We
modiﬁed a previously-reported treadmill walking test protocol and
explored its capacity to measure analgesic efﬁcacy at baseline and
during paced walking. We hypothesized this would facilitate subject
enrollment and provide direct static and dynamic assessments of KOA
pain intensity and a response to acute treatment with conventional
doses of naproxen.
Methods: This was a randomized, double-blind, 3-period crossover
study performed at one site. Subjects with documented KOA were
screened to conﬁrm that their pain intensity (PI) scores were > 1 point
higher on an 11 point NRS scale after two weeks withdrawal of their
regularly prescribed NSAID. They thenwere randomized (1:1) to receive
different sequences of three 4-day courses of blinded capsules of BID
doses of 500mg naproxen (N) or placebo (P): N-P-P or P-N-N with 4 day
inter-period washouts. At each visit, the treadmill walking protocol
required four 20-min walks with 40 min rest periods. Subjects had one
predetermined self-paced (SP) walk prior to dosing on Day 4, then took
